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Reprogramming of somatic cells achieved by combi-
nation of the four transcription factors Oct4, Sox2,
Klf4, and c-Myc has very low efficiency. To increase
the reprogramming efficiency and better understand
the process, we sought to identify factors that
mediate reprogramming with higher efficiency. We
established an assay to screen nuclear fractions
from extracts of pluripotent mouse cells based on
Oct4 reactivation. Using proteomics, we identified
components of the ATP-dependent BAF chromatin-
remodeling complex, which significantly increases
reprogramming efficiency when used together with
the four factors. The reprogrammed cells could
transmit to the germline and exhibited pluripotency.
Reprogramming remained highly efficient when
c-Myc was not present but BAF components were
overexpressed. BAF complex components mediate
this effect by facilitating enhanced Oct4 binding to
target promoters during reprogramming. Thus,
somatic cell reprogramming using chromatin-re-
modeling molecules represents an efficient method
of generating reprogrammed cells.INTRODUCTION
Somatic cell reprogramming using transduction with the tran-
scription factors Oct4, Sox2, Klf4, and c-Myc—i.e., the ‘‘four
factors’’—has been shown to reset mouse and human somatic
cell programs to a pluripotent embryonic stem cell (ESC)-like
state (Meissner et al., 2007; Park et al., 2008; Takahashi et al.,
2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007;
Yu et al., 2007). However, we have recently found that Oct4 alone
is both necessary and sufficient to reprogram neural stem cells
(Kim et al., 2009b, 2009c).Transcription factor-mediated reprogramming is achieved
through stochastic events, resulting in very low reprogramming
efficiency (Yamanaka, 2009). To address the heterogeneity in
reprogramming factor expression, a secondary reprogramming
system with consistent factor expression was developed,
increasing reprogramming efficiency to 4.5% (Wernig et al.,
2008). In contrast with somatic cell nuclear transfer, 45%–
50% of somatic cell nuclei consistently undergo reprogramming
in 3.5 days (Markoulaki et al., 2008). Four factor-mediated
generation of induced pluripotent stem (iPS) cells can be
achieved in 2–3 weeks, whereas protein transduction-medi-
ated iPS cell generation takes 10–12 weeks (Kim et al.,
2009a; Zhou et al., 2009). Fusion of somatic cells with pluripotent
cells is the fastest and most efficient method, with reprog-
rammed cells observed within 1 day (Han et al., 2008). These
data suggest that there may be additional or alternate reprog-
ramming factors that can reduce the duration of reprogramming
and thus improve reprogramming efficiency.
In this study, we developed a combined functional and quan-
titative proteomics screen to identify proteins and complexes
that contribute to reprogramming. The SWI/SNF complex, found
to be enriched in reprogramming-competent fractions of cell
extracts from pluripotent cells, significantly increased the effi-
ciency of four factor-mediated reprogramming. BAF complex
overexpression can replace c-Myc and lead to reprogrammed
cells that exhibit pluripotency and in vivo developmental poten-
tial equivalent to that of ESCs. A mechanistic insight into BAF
complex function reveals that BAF complex components
achieve a euchromatic chromatin state and enhance binding of
reprogramming factors onto key pluripotency gene promoters,
thereby enhancing reprogramming.
RESULTS
Screening Assay for Identification of Reprogramming
Factors
To identify reprogramming factors, we established an assay to
screen proteins from various fractions of pluripotent cell
extracts. We tested the digitonin- (Hansis et al., 2004) andCell 141, 943–955, June 11, 2010 ª2010 Elsevier Inc. 943
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Figure 1. Screening Assay for Identification of Reprogramming Factors
(A) Schematic representation of screening assay.
(B) MEFs were first treated with 400 ng/ml of streptolysin ‘O’ and then with WCE from the cell type shown.
(C) MEFs were treated with 200 ng/ml of streptolysin ‘O’ (cond. 1) or with 400 ng/ml (cond. 2) of streptolysin ‘O’ and then treated with F9 WCE. RNA was extracted
on days 1 (18 hr post-treatment), 4, 7, and 11 to analyze Oct4 expression. b-actin was used as a loading control.
(D) MEFs were treated with F9 WCE or F9 WCE treated with benzonase, and cells were then treated with increasing amounts (50, 100, 200, 400, 800, and 1000 ng/
ml) of streptolysin ‘O’ (SLO) and Oct4 expression was analyzed. b-actin was used as a loading control.
See also Figure S1.streptolysin ‘O’-based (Taranger et al., 2005) methods to per-
meabilize cells and used primary mouse embryonic fibroblasts
(MEFs) as the somatic cell source. Digitonin gave good induc-
tion of pluripotency genes (Figure S1A available online), with
Gfp transcripts (Figure S1B) also detected, indicating reactiva-
tion of the Oct4 transgene in OG2MEFs (Pesce et al., 1998);
however, no viable cells were obtained. The streptolysin
‘O’-based protocol resulted in weak pluripotent gene induction
(Neri et al., 2007) (Figure S1C), with reproducibility being
a concern (Miyamoto et al., 2007). To optimize this protocol,
we used adherent cells pretreated with Ca2+-free medium.
Primary MEFs were treated with whole-cell extracts (WCEs)
from four different pluripotent cells: F9 embryonic carcinoma
cells, D3 mouse ESCs, Nulli cells, a mutated cell line obtained
from F9 cells, and NIH 3T3 cells. Oct4 expression was signifi-
cantly increased in MEFs after treatment with extract from D3
ESCs and also detected after treatment with F9 or Nulli cell
WCE. Expression of Rex1, but not that of other pluripotency-944 Cell 141, 943–955, June 11, 2010 ª2010 Elsevier Inc.related genes, Sox2, Klf4, c-Myc, and Nanog, was significantly
increased in MEFs after treatment with pluripotent cell extracts
(Figure 1B), although the treated MEFs retained a fibroblast
morphology. To rule out that Oct4 transcripts had originated
from the pluripotent cell extracts, rather than being re-ex-
pressed by MEFs, and to determine if Oct4 activation was
transient or stable, MEFs treated with F9 WCE were cultured
for about 2 weeks and Oct4 expression examined. Oct4
expression increased from days 1 to 4 post-treatment and
was maintained until at least day 11, indicating that it was
due to endogenous (de novo) transcription and that the Oct4
promoter undergoes stable activation upon treatment with
cell extract (Figure 1C). To rule out any RNA contamination
from the extracts, WCEs were also treated with benzonase,
a nuclease that digests DNA and RNA. Benzonase treatment
did not interfere with Oct4 expression in MEFs; rather, it
reduced the amount of streptolysin ‘O’ required to induce
Oct4 expression (Figure 1D).
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Figure 2. Identification of Components of
the SWI/SNF Complex
(A) Schematic representation of fractionation.
(B) Permeabilized MEFs were treated with F9
whole-cell extract (WCE), F9 nuclear extract (NE),
and various fractions. RNA was extracted 18 hr
post-treatment and analyzed by real-time PCR
for the expression of pluripotency markers. Data
are represented as fold expression compared to
the expression in F9 NE-treated cells.
(C) Expression of reprogramming factors Oct4,
Sox2, Klf4, as well as of Brg1 was detected by
western blotting with F9 WCE, F9 NE, F9 cyto-
plasmic extract, F9 Fraction 1, F9 Fraction 2, and
F9 Fraction 3.
(D) Schematic representation of sample prepara-
tion for SILAC-based LC-MS/MS analysis.
(E) Direct acyclic graph (DAG) associated to the six
top higher significant enriched gene ontology
‘‘cellular component’’ terms. Box color codifies
significance, ranging from red (most significant)
to green (least significant). Numbers in the bottom
color bar represent the magnitude of the p values
associated with the respective color. The signifi-
cant enriched terms are encircled by ellipses.
(F) Representation of components of SWI/SNF
complex. SILAC ratios (Heavy/Light) smaller than
1 indicate the enrichment of the SWI/SNF complex
in Fraction 1 from F9 (light) over Fraction 1 from
NIH 3T3 cells (heavy).
See also Figure S2 and Tables S1 and S2.Identification of BAF Complex Components
from Reprogramming-Competent F9 Fraction
F9 pluripotent cell extracts were fractionated to enrich any
proteins that play a role in reprogramming. WCE from F9 ESC
produced similar reactivation of Oct4 expression in MEFs as
WCEs from other pluripotent cells (Figure 1B). F9 proteins were
fractionated into nuclear and cytoplasmic fractions and F9
nuclear extracts (NEs) were further separated using Q-sepharose
FF chromatography (Figure 2A and Figure S2B). The NEs were
still capable of reactivating Oct4 expression, indicating that
they retained the factors required forOct4 expression, consistent
with a published study demonstrating that reprogramming
factors exist in the nucleus (Do and Scho¨ler, 2004) and that the
nuclear extraction procedure did not affect the activity of reprog-
ramming factors. Furthermore, Fraction 1 (F1) of the NE was
capable of reactivating Oct4 expression in MEFs, whereas Frac-
tion 2 (F2) and Fraction 3 (F3) were not (Figure S2A). Oct4 activa-
tion was slightly increased by F1 compared with the complete
NE, showing partial enrichment of reprogramming factors
(Figure 2B). Western blot analysis using various fractions was
carried out to determine the distribution of the transcriptionCell 141, 943–9factors involved in reprogramming. Oct4,
Sox2, and Klf4 could only be detected in
F1 (Figure 2C). Treatment of MEFs with
F1 led to reactivation of endogenous
Oct4 expression in just 18 hr, whereas
retrovirus-mediated three-factor overex-pression led to induction of endogenous Oct4 expression in 3
weeks. The presence of the reprogramming factors and the
completion of Oct4 reactivation within 1 day indicate that F1
contains all factors required for efficient reprogramming. As F1
contained thousands of proteins (Figure S2B, and see below),
additional methods were established to identify pluripotent cell-
specific reprogramming factors.
Mass spectrometry (MS)-based proteomics was used with an
unrelated reprogramming-incompetent cell line to stringently
select for alternate reprogramming factors. Using SILAC, the
lysine residues of proteins in NIH 3T3 cells were labeled,
increasing the molecular weight of each lysine by 8 Da (Mann,
2006; Ong et al., 2002). Mean labeling efficiency of NIH 3T3 cells
was 97% after five passages (Figure S2C). MaxQuant algo-
rithms, which also calculated the exact heavy/light isotope
(H/L) ratio of each protein (Cox and Mann, 2008) identified nearly
5,000 different proteins from mixed F1 fractions of F9 NE and
NIH 3T3 NE. Pluripotent cell-enriched proteins were identified
by a lower H/L ratio (Figure 2D). Specific factors, including
Oct4, Sall4, Rif1, Esrrb, and Lin28 (Figure 2F and Table S1),
were labeled as extreme cases and served as positive controls.55, June 11, 2010 ª2010 Elsevier Inc. 945
Gene ontology enrichment analysis was performed to deter-
mine the enrichment of pluripotency-associated factors based
on H/L ratio (Experimental Procedures). Chromatin remodeling
terms ranked top of significantly enriched ‘‘cellular component’’
terms, with the highest enriched term belonging to SWI/SNF
complex proteins (Figure 2E and Table S2). All subunits were
several-fold overrepresented in the reprogramming-competent
fraction compared with the unrelated cell extract (Figure 2F).
Smarcc2/Baf170, the only exception, showed enrichment in
the NIH 3T3 fraction, consistent with its somatic cell-specific
expression (Ho et al., 2009b).
Smarca4/Brg1, an ATPase subunit of the SWI/SNF chromatin-
remodeling complex (Wang, 2003), was detected at 7-fold higher
ratio in the reprogramming-competent fraction. Smarcd1/
Baf60a, Arid1a/Baf250a, Arid1b/Baf250b, and Smarcc1/Baf155
components were also highly enriched and have recently been
shown to bind together and form esBAF complex (Gao et al.,
2008; Ho et al., 2009b; Yan et al., 2008).
Pluripotent Cell-Specific BAF Complex Enhances Four
Factor-Mediated Reprogramming of Somatic Cells
Smarca4/Brg1, Smarcb1/Ini1, Smarcc1/Baf155, and Smarcc2/
Baf170 subunits are sufficient to constitute SWI/SNF complex
activity (Phelan et al., 1999). Ini1 and Baf170 are present at
a significant level in NIH 3T3 (Figure 2F); only Brg1 and Baf155
were transduced in combination with Oct4, Sox2, Klf4, and c-
Myc (OSKM). Thus, 50,000 OG2MEFs were transduced with
either the OSKM retroviruses or with the OSKM retroviruses
plus those for Brg1 and Baf155 (OSKMBB). Overexpression of
Brg1 and Baf155 resulted in about a 4-fold increase in GFP+ colo-
nies on day 12. Fluorescence-activated cell sorting (FACS)
showed that OSKM- and OSKMBB-mediated reprogramming re-
sulted in 0.8% and 4.5% GFP+ cells, respectively (Figure 3B).
GFP+ colonies produced by OSKMBB were more homogeneous
and more compact than those produced by OSKM (Figure 3A).
Therefore, we conclude that overexpression of Brg1 and
Baf155 significantly enhances OSKM-mediated reprogramming.
Reprogramming mediated by the four factors passes through
an intermediate stage marked by SSEA1+ GFPcells (Brambrink
et al., 2008), hence cells were FACS analyzed to determine the
stage at which Brg1 and Baf155 act to enhance reprogramming.
When Brg1 and Baf155 were added to the four factors, there was
an1.5-fold increase (13.5% to 21.9%) in the number of SSEA1+
cells and an 5-fold increase (0.5% to 2.5%) in the number of
SSEA1+ GFP+ cells (Figure 3D). Thus, Brg1 and Baf155 are likely
to play a role at this intermediate stage of reprogramming.
Oct4, Nanog, and Rex1 Promoters Are Demethylated
Faster in Brg1- and Baf155-Mediated Reprogramming
Epigenetic modification of promoters of pluripotency genes in
GFP+ cells obtained by either OSKM or OSKMBB was assessed
to confirm the reprogramming of endogenous genes. GFP+ cells
were FACS sorted at passage 0 (P0), i.e., immediately after the
appearance of GFP+ colonies. The Oct4, Nanog, Rex1, and
Fbx15 promoters of OSKM-mediated reprogrammed cells were
57%, 58%, 63%, and 30% methylated, respectively, whereas
those of OSKMBB-mediated reprogrammed cells were 18%,
16%, 38%, and 29% methylated, respectively (Figure 4A). After946 Cell 141, 943–955, June 11, 2010 ª2010 Elsevier Inc.further passage of GFP+ cells, the Oct4, Nanog, Fbx15, and
Rex1promoters in both types of reprogrammed cells were deme-
thylated (Figure 4B), demonstrating that the cells had undergone
complete reprogramming. Thus, Oct4, Nanog, and Rex1
promoters undergo faster demethylation in cells reprogrammed
using Brg1 and Baf155 in combination with the four factors
compared with those reprogrammed using only the four factors.
To assess whether faster demethylation in OSKMBB-mediated
reprogramming is due to changes in the cell cycle, OG2MEFs
infectedwitheitherOSKMorOSKMBBretroviruseswerecompared
5 days after infection. 17.3% of OSKM retrovirus-infected cells and
19.4% of OSKMBB retrovirus-infected cells were in the S phase
(Figure 4C), showing no significant cell cycle changes.
OSKMBB-iPS Cells Have Gene Expression Profile
Similar to that of ESCs
RT-PCR analysis showed OSKMBB-iPS cells expressed pluripo-
tency-related genes, including Oct4, Sox2, Nanog, Fgf4, and
Baf155, at levels comparable to those of ESCs (Figure 5A). Retro-
viral silencing of OSKMBB-iPS cells (Figure 5B) and genomic inte-
gration of reprogramming factors was confirmed (Figure 5C).
Global gene expression profiles of OG2MEF, OG2ES, OSKM-
iPS, and OSKMBB-iPS cells, as assessed by pairwise scatter
plot of DNA microarray data, demonstrated high similarity
between OSKM-iPS cells, OSKMBB-iPS cells, and ESCs (Figures
5D–5F). Heat map and hierarchical clustering confirmed the simi-
larity of OSKMBB-iPS cells and ESCs (Figures 5G and 5H).
Differentiation and Developmental Potential
of OSKMBB-iPS Cells Reveals Similarity to ESCs
The differentiation potential of OSKMBB-iPS cells was assessed
by embryoid body (EB) and teratoma formation. EBs cultured in
the presence of retinoic acid for 5 days contained cells positive
for ectodermal (Tuj1), endodermal (a-Fetoprotein), and meso-
dermal (T/Brachyury) markers (Figure 6A) and could also be differ-
entiated into beating cardiomyocytes (Movie S1). Subcutaneous
injection of OSKMBB-iPS cells into nude mice resulted in tera-
tomas with tissues of all germderivatives, including skinepithelium
(ectoderm), muscle (mesoderm), and cuboidal epithelium (endo-
derm) (Figure 6B). These tests show that OSKMBB-iPS cells are
capable of differentiating into derivatives of all three germ layers.
To assess their developmental potential, OSKMBB-iPS cells
were aggregated with eight-cell embryos. Upon culture in vitro,
these OSKMBB-iPS cells contributed to the inner cell mass of
the developing blastocyst (Figure 6C), and, after transfer of the
aggregated blastocysts into pseudopregnant mice, they
contributed to the germline, as detected in day 13.5 embryos
(Figure 6D). Furthermore, these aggregated blastocysts
produced animals with high coat color chimerism (Figure 6E).
To assess whether the OSKMBB-iPS cells have the capacity
for germline transmission, the chimeras were mated with CD-1
female mice. Three of five pups had an Oct4-GFP allele of the
donor cells, as judged by GFP expression in ovaries or testes
of the pups (Figure 6F). These findings indicate that OSKMBB-
iPS cells can contribute to the full-term development of
chimeras, resulting in the first generation (F1) of viable pups,
and thus suggest that OSKMBB-iPS cells have a developmental
capacity similar to that of ESCs.
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Figure 3. Role of the SWI/SNF Complex in Four Factor-Mediated Reprogramming
(A) Morphology and GFP expression of OSKM and OSKMBB iPS cells.
(B) FACS analysis of OSKM and OSKMBB iPS cells after day 12 post-infection. Percentage of GFP+ cells in each population is indicated.
(C) Number of GFP+ colonies in OSKM and OSKMBB iPS cells on days 12 and 21 post-infection. Data represent mean ± SEM of three retrovirus-mediated trans-
ductions (n = 3).
(D) FACS analysis of SSEA1-stained OSKM and OSKMBB iPS cells on day 12 post-infection. Percentage of SSEA1+ GFP cells and of SSEA1+ GFP+ cells is
indicated.Brg1 and Baf155 Synergistically Increase Efficiency
of OSK-Mediated Reprogramming
To test whether Brg1 or Baf155 could enhance the efficiency of
reprogramming mediated by Oct4, Sox2, and Klf4—i.e., in
absence of c-Myc—OG2MEFs were transduced with differentcombinations of retroviruses (OSK retroviruses were always
included). OSK-Brg1 resulted in significantly more GFP+ colo-
nies compared with OSK, but OSK-Baf155 resulted in approxi-
mately five times more GFP+ colonies, a difference maintained
until day 21 after infection (Figure 7A). OSK-Brg1-Baf155Cell 141, 943–955, June 11, 2010 ª2010 Elsevier Inc. 947
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Figure 4. Methylation Analysis of Endoge-
nousPluripotency-SpecificGenePromoters
(A) Analysis of Oct4, Nanog, Rex1, and Fbx15
promoters by bisulfite sequencing immediately
after the appearance of GFP+ colonies in the
OSKM and OSKMBB populations. GFP+ cells
were FACS sorted and genomic DNA was iso-
lated.
(B) Analysis of Oct4, Nanog, Rex1, and Fbx15
promoters of OSKM-iPS and OSKMBB-iPS cells
after passage 12.
(C) The cell cycle of OG2MEFs transduced with
either OSKM or OSKMBB was analyzed on day 5
post-infection by using DAPI incorporation. Data
were analyzed by FlowJo software.resulted in 12 times more GFP+ colonies than OSK. Thus, Brg1
and Baf155 acted to synergistically enhance reprogramming
efficiency in the absence of c-Myc.
Brg1 Plus Baf155 Achieves Euchromatin and Enhances
Binding of Oct4
We next compared the histone methylation patterns during re-
programming mediated by OSK (3F) or OSK-Brg1-Baf155 (5F).
Brg1-Baf155 significantly increased the activation marks
H3K4me3 on Tcf3, Oct4A, Oct4B, and Lefty2 promoter regions
(Figures 7B and 7C) and H3K9Ac on Tcf3 and Lefty2 promoters948 Cell 141, 943–955, June 11, 2010 ª2010 Elsevier Inc.(Figure 7D). The repression mark
H3K27me3 was not significantly en-
riched on the above gene promoters
(data not shown), but it was significantly
reduced on the pluripotency-specific
gene Sall4 promoter (Figure 7E). Thus,
Brg1 and Baf155 appear to convert
a passive chromatin state into a euchro-
matic chromatin state. To test whether
Brg1 and Baf155 enhance binding of
factors onto their target promoters
during reprogramming, binding of Oct4
onto the above gene promoters was as-
sessed. The Dppa4 gene was also
included, as Dppa4 is not only
a common target of Oct4, Sox2, and
Klf4 (Sridharan et al., 2009) but also of
Brg1 (Ho et al., 2009a). OG2MEFs
were transduced with OSK retroviruses
with or without Brg1 plus Baf155, and
Oct4 binding was assessed by
chromatin immunoprecipitation (ChIP)
9 days after infection. Brg1 plus
Baf155 significantly enhanced Oct4
binding onto Sall4, Tcf3, and Dppa4
promoters, as well as both Oct4
promoter regions, but did not affect
that onto the Lefty 2 promoter (Figures
7F and 7G). Thus, Brg1 and Baf155enhance reprogramming by achieving a euchromatic chromatin
state and enhancing binding of reprogramming factors onto key
reprogramming gene promoters.
DISCUSSION
To our knowledge, this is the first study showing that a specific
chromatin-remodeling complex plays a role in the generation
of iPS cells through somatic cell reprogramming. Along with its
bona fide function in rearranging nucleosomes, the SWI/SNF
complex regulates gene expression through interactions with
repressors, including Dnmt3a/3b, Mbd3, and MeCP2 (Datta
et al., 2005; Harikrishnan et al., 2005; Ho et al., 2009b).
We demonstrated that the BAF complex increases the reprog-
ramming efficiency mediated by the ‘‘four factors.’’ Brg1 has
been implicated in reprogramming using cell extract-based
methods (Hansis et al., 2004) and its knockdown has been
shown to affect Oct4 expression (Ho et al., 2009a, 2009b; Kidder
et al., 2009). These and other studies indicate that the BAF
complex is involved in regulating pluripotency gene expression,
which may enhance reprogramming efficiency. In addition, the
interaction between c-Myc and Ini1, a component of the SWI/
SNF complex, is required for the transactivation function of
c-Myc (Cheng et al., 1999). Therefore, increased SWI/SNF
complex levels, together with the four factors, may enhance
c-Myc-mediated transactivation of various genes required for
reprogramming, thus improving efficiency of iPS cell formation.
Overexpression of the BAF complex during four factor-medi-
ated reprogramming increases the kinetics of Oct4, Nanog,
and Rex1 promoter demethylation. The SWI/SNF complex has
been postulated to play a role in demethylation of CD44 and
E-cadherin promoters, as loss of Brg1/Brm results in hyperme-
thylation (Banine et al., 2005). The SWI/SNF complex may regu-
late DNA methylation either directly—i.e., by recruiting DNA
methylases—or indirectly—i.e., by altering the expression of
other proteins affecting DNA methylation. Brg1 has been shown
to interact with the DNA methylation enzymes Dnmt3a in
lymphosarcoma cells (Datta et al., 2005) and Dnmt3b in ESCs
(Ho et al., 2009b). Thus, Brg1 may recruit Dnmt3a/b onto
promoters of pluripotency genes, including Oct4, Nanog, and
Rex1, during reprogramming, thereby initiating DNA demethyla-
tion and improving reprogramming efficiency.
The BAF complex enhanced the efficiency of reprogramming
mediated by Oct4, Sox2, and Klf4, which is important consid-
ering that c-Myc can activate several tumor pathways, resulting
in reprogrammed cells that may be unsuitable for clinical appli-
cations. In contrast, the SWI/SNF complex has been shown to
act as a tumor suppressor in various cell types (Reisman et al.,
2009; Roberts and Orkin, 2004) and in the mouse (Bultman
et al., 2000).
Using ChIP analysis, enhanced Oct4 binding onto various plu-
ripotency gene-specific promoters was found in the presence of
BAF components. The cells were analyzed at an intermediate
stage of reprogramming and in some cases the changes were
small, which may be due to the fact that only a very small popu-
lation of cells is undergoing reprogramming. As purification of
partially reprogrammed cells was not feasible due to a very low
cell number, we performed real-time analysis of the whole cell
population, which is undergoing an intermediate stage of the re-
programming process. We were able to convincingly demon-
strate that Oct4 binding onto Dppa4 promoter, for example, is
enhanced in the presence of BAF components. Of the promoters
tested, only Dppa4 is a target of Oct4, Sox2, and Klf4 as well as
of Brg1, which may explain the several-fold increase in Oct4
binding to Dppa4. Increased Oct4 binding was shown for Oct4
and Sall4 promoters, for example, in the presence of BAF
components, but no Oct4 binding was observed in the absence
of BAF components. These results clearly show that Oct4
binding onto various promoters is enhanced in the presenceof BAF components, thereby facilitating reprogramming. Inter-
estingly, the BAF complex has been shown to play a role in main-
taining Oct4 expression levels (Ho et al., 2009a, 2009b; Kidder
et al., 2009).
Most targets of the four factors have been shown to be meth-
ylated at K4 in ESCs, a pattern also observed in fibroblasts and
partially reprogrammed cells (Sridharan et al., 2009). OSK
targets, such as Tcf3 and Lefty2, have also been shown to
have an intermediate pattern of histone methylation (Sridharan
et al., 2009), consistent with our findings showing H3K4me3 on
Tcf3 and Lefty2 promoters at an intermediate stage of reprog-
ramming using 3F-mediated reprogramming. These promoters
show increased H3K4me3 at an intermediate stage of reprog-
ramming using Brg1 plus Baf155 in combination with the 3F.
Additionally, a substantial increase in H3K9Ac histone acetyla-
tion level in the presence of Brg1 and Baf155 led us to conclude
that the BAF complex can enhance reprogramming by
increasing the euchromatic state during 5F-mediated reprog-
ramming compared to 3F-mediated reprogramming. Our results
show that the BAF complex, like c-Myc, facilitates reprogram-
ming factor binding independent of histone methylation, thereby
enhancing reprogramming efficiency.
In this study, we found that when Baf155 is overexpressed
along with OSK, reprogramming efficiency is enhanced. It is
likely that Baf155 enters the endogenous BAF complex and
replaces Baf170, converting the complex to esBAF or a similar
complex and thereby enhancing efficiency of pluripotency cell-
specific functions mediated by chromatin remodeling. We also
found that when Brg1 and Baf155 are overexpressed together,
they increase the reprogramming efficiency in a synergistic,
rather than additive, manner. This observation suggests that
when both the factors are overexpressed simultaneously they
form a subcomplex probably by using some of the endogenous
components of the SWI/SNF complex in addition to entering
endogenous BAF complexes. Thus, it appears that an increase
in reprogramming efficiency due to Brg1 and Baf155 overex-
pression could be due to either weakening of somatic cell-
specific BAF complexes or formation of small subcomplexes
that support reprogramming function.
We also observed that the Brg1-containing SWI/SNF complex
acts at an intermediate stage of reprogramming. The identifica-
tion of additional reprogramming factors, which can either affect
the four factor-mediated reprogramming or independently
reprogram cells more efficiently, should help elucidate the
underlying mechanisms regulating the reprogramming process
and enable us to harness our resources to reprogram cells in
a very efficient and highly regulated manner.EXPERIMENTAL PROCEDURES
Cell Culture
F9, Nulli-SCC1, NIH 3T3, and Plat-E (Morita et al., 2000) cells were maintained
in high-glucose DMEM (PAA) containing 10%FBS, 13 penicillin/streptomycin/
glutamine (PSG) (PAA). F9 cells were maintained on gelatin-coated plates;
Nulli-SCC1 cells were maintained in suspension. For maintaining Plat-E cells,
1 mg/ml of puromycin (Sigma), and 100 mg/ml of blasticidin S was added into
the culture medium. ESCs were maintained in knockout DMEM containing
15% knockout serum replacement (Invitrogen), 5%FBS, 13 PSG, 13 nones-
sential amino acids (NEAA) (PAA), and 13 b-mercaptoethanol (Invitrogen) withCell 141, 943–955, June 11, 2010 ª2010 Elsevier Inc. 949
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Figure 5. Gene Expression Profiles of iPS Cells
(A) Expression of various pluripotency markers and reprogramming factors was analyzed by TaqMan-based real-time PCR. Gene expression is represented as
fold expression compared with that of feeder-dependent OG2ES cells.
(B) Transgene expression after retroviral-mediated transduction of reprogramming factors and silencing of transgene expression was analyzed by TaqMan-
based PCR. Data are represented as fold expression compared with that of day 5 OSKMBB cells.
(C) Genotyping of OSKM-iPS and OSKMBB-iPS cells at passage 0 (P0) and passage 12 (P12) along with tail and gonad tissues from first generation (F1) of mice
was carried out using TaqMan-based real-time PCR. Data are presented as Ct values. Ct value of 40 indicates no expression.
(D–F) Pairwise scatter plots of global gene expression cDNA microarray patterns of OSKMBB-iPS (iPS6F) cells compared with either MEFs (D), feeder-dependent
OG2ES cells (E), or OSKM-iPS (iPS4F) cells (F). Black lines indicate log2 2-fold changes in gene expression levels between the paired cell types. Upregulated
950 Cell 141, 943–955, June 11, 2010 ª2010 Elsevier Inc.
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Figure 6. Pluripotency and In Vivo Developmental
Potential of OSKMBB-iPS Cells
(A) Embryoid bodies (EBs) generated by OSKMBB-iPS cells
and differentiated for 5 days in the presence of 5 mM retinoic
acid. Cells were stained with anti-TuJ1, anti-Brachyury, and
anti-Sox17 antibodies to identify ectoderm, mesoderm, and
endoderm lineages, respectively.
(B) Representative tissues of ectodermal (skin epithelium),
mesodermal (muscle), and endodermal (cuboidal epithelium)
lineages in teratomas obtained from OSKMBB-iPS cells.
(C) Contribution of OSKMBB-iPS cells into blastocyst.
(D) Germline contribution of OSKMBB-iPS cells.
(E) Chimeric mice (*) obtained from OSKMBB-iPS cells.
(F) Male and female gonads from F1 pups obtained by mating
OSKMBB-iPS cell-generated chimeric mice with CD-1 female
mice.2000 units of leukemia inhibitory factor (LIF) on gelatin-coated plates. iPS cells
were maintained on feeder layers of mitomycin C-treated MEF cells as previ-
ously described (Kim et al., 2008) and passaged every 3 days. MEFs were
isolated as described previously (Takahashi and Yamanaka, 2006) and main-
tained in low-glucose DMEM containing 10% FBS (Biowest), 13 PSG,
13 NEAA, and 13 b-mercaptoethanol. In this study, we used MEFs withingenes in ordinate samples compared with abscissa samples are shown in blue; those downregu
Oct4, Sox2, Nanog, Klf4, and Lin28) are shown as green dots. Gene expression levels are in log
(G) Heat map of global gene expression. Gene expression color key in log2 scale is depicted on
(H) Hierarchical clustering of global gene expression, with red branches clustering pluripotent ce
Cell 1five passages to avoid replicative senescence, as suggested
by previous studies (Takahashi and Yamanaka, 2006).
Cell Permeabilization and Extract Treatment
One hundred thousand MEFs were plated per well of a gelatin-
coated 96 well plate. Cells were washed once with Ca2+-free
DMEM and further incubated in Ca2+-free DMEM (Invitrogen)
for 30 min. Streptolysin ‘O’ was added for 15 min. After incu-
bation, cells were washed once with Ca2+-free DMEM. 75 ml
of extracts (equivalent to about 1300 mg WCE, 380 mg NE,
and 150 mg fraction protein) supplemented with 9 ml of ATP
generating system (Taranger et al., 2005) were added onto
the permeabilized cells for 1 hr at 37C. After incubation,
high-glucose DMEM containing 10% FBS, 13 PSG, and
2 mM CaCl2 was added for 2 hr. Cells were then washed twice
with prewarmed knockout DMEM and cultured for another
18 hr in complete ESC medium or at other time points as
stated with respective experiments, after which RNA was
extracted and analyzed by quantitative PCR or semiquantita-
tive PCR using 35 cycles of PCR.
Extract Preparation and Fractionation
Whole-cell extracts from F9 cells, ESCs, and Nulli cells were
prepared as described previously (Taranger et al., 2005).
Extracts were filtered through HPF Millex-HV (Millipore) filters
containing glass fibers and 0.45 mm durapore membrane and
then through 0.45 mm Millex-HV filters (Millipore). Nuclear
extracts were prepared as described previously (Dignam
et al., 1983) with minor modifications. Briefly, cells were
collected by trypsinization, washed twice in ice-cold PBS,
washed once in swelling buffer (10 mM KCl, 10 mM HEPES
[pH 7.9], 1.5 mM MgCl2, 2 mM DTT, 0.5 mM PMSF) and resus-
pended in swelling buffer for an additional 30 min on ice. Nuclei
were isolated using a dounce homogenizer and their puritywas verified by microscopy. Nuclei were washed once in swelling buffer and
incubated in nuclear extraction buffer (420 mM KCl, 20 mM HEPES [pH 7.9],
1.5 mM MgCl2, 0.5 mM EDTA, 25% glycerol, 2 mM DTT, 0.5 mM PMSF) for
1 hr at 4C. Nuclear extracts were fractionated using Q-sepharose FF chroma-
tography and desalted using Micro Biospin chromatography columns (Bio-
Rad) before being used for screening.lated are shown in red. Positions of pluripotent genes (Pou5f1/
2 scale.
top.
ll populations.
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Figure 7. Role of SWI/SNF Complex during
Reprogramming in the Absence of c-Myc
(A) Number of GFP+ colonies on days 12 and 21
post-infection. Data represent mean ± SEM of
three retrovirus-mediated transductions (n = 3).
(B–G) ChIP analysis was carried out on day 9 post-
infection for H3K4me3 (B and C), H3K9Ac (D),
H3K27me3 (E), and Oct4 (F and G) on various
promoters. Dppa4 30UTR was used to normalize
the amount of precipitated DNA. Data shown in
(B–G) are mean ± SEM of duplicates (n = 2).SILAC Labeling and Data Analysis
NIH 3T3 cells were SILAC labeled essentially as described previously
(Graumann et al., 2008), solely using lysine (13C6,
15N2). Fractions obtained
from the F9 nuclear extract and heavy-labeled NIH 3T3 nuclear extract were
mixed together at a ratio of 1:1 by protein concentration and subjected to in-
solution digestion with Lys-C. After separation into 12 fractions by in-solution
isoelectric focusing with the Agilent OFFGEL 3100 separator, fractions were
analyzed by LC-MS/MS using an easy-nLC (Proxeon) coupled to an Orbitrap
(ThermoFisher Scientific). Recorded data were analyzed with MaxQuant (Cox
and Mann, 2008) (version 1.0.12.19), using the IPI mouse database (v. 3.51),
allowing for two missed cleavages, requiring a minimum of six amino acids
per peptide, and filtering results to a false discovery rate of 1% on the peptide
and protein levels. In brief, SILAC ratios are derived from volume comparison of
isotope clusters reconstructed in three dimensions (m/z, intensity, and elution
time) from recalibrated high-resolution mass spectra. After identification via the952 Cell 141, 943–955, June 11, 2010 ª2010 Elsevier Inc.MASCOT search algorithm, candidate peptide
sequences are filtered for mass precision as well
as the SILAC state observed with respect to the
precursor ion. Resulting peptide sequences are
assembled to proteins and the associated ratios
averaged to a protein ratio. Plotting and down-
stream data analyses were performed using the
R language.
Gene Ontology Enrichment Analysis
The significance of the gene ontology terms of the
different expressed proteins was analyzed using
an enrichment approach based on the hypergeo-
metric distribution. To build the background set of
genes, we used a set of 5111 genes detected
using SILAC in ESCs (Graumann et al., 2008).
We sorted the list of proteins in the enriched frac-
tion from the lowest to highest H/L ratio and
filtered up the cases with H/L ratio lower than
0.2. Such a list was used to perform ontology
enrichment analysis, based on the terms of
AMIGO gene ontology (Ashburner et al., 2000)
with respect to the aforementioned ESC back-
ground. The gene ontology terms were back prop-
agated from the final term appearing in the gene
annotation until the root term of each ontology.
The significance (p value) of the gene ontology
terms enrichment was calculated using the hyper-
geometric distribution and the multitest influence
was corrected through controlling the false
discovery rate using the Benjamini and Hochberg
correction at a significance level of a = 0.05.
Retroviral Infection
The day before transfection, PLAT-E cells were
seeded at a density of 5 3 105 cells per 60 mm
dish. On the next day, pMXs-based retroviralvectors were introduced into PLAT-E cells using Fugene 6 transfection reagent
(Roche), according to the manufacturer’s recommendations. 9 ml of Fugene 6
transfection reagent was diluted in 200 ml of DMEM and incubated for 5 min at
room temperature (RT). 3 mg of plasmid DNA was added to the mixture, which
was then incubated for 15 min at RT. After incubation, the DNA/Fugene 6
mixture was added drop by drop onto the PLAT-E cells. Cells were then incu-
bated overnight at 37C with 5% CO2. 24 hr after transfection, the medium was
replaced with 3 ml of fresh medium, and after another 24 hr, virus-containing
supernatant was collected. Virus-containing supernatants derived from these
PLAT-E cultures were filtered through 0.45 mm Millex-HV (Millipore) filters and
supplemented with 6 mg/ml of protamine sulfate (Sigma). MEFs were seeded at
a density of 53 104 cells per well of a 6-well plate in the presence of c-Myc, in
the case of infection, or at a density of 13 105 cells per well of a 6-well plate in
the absence of c-Myc on a gelatin-coated plate. Virus-containing supernatant
was added onto the OG2MEF cells. Supernatant obtained from empty vector
transfection was used to normalize the viral supernatant in different infections.
18 hr later, virus-containing supernatant was removed and cells were washed
twice with PBS. Infected cells were maintained in culture for 5 days in high-
glucose DMEM containing 10% FBS and 13 PSG, with medium change after
the third day. Five days later, the medium was replaced with ESC medium
without c-Myc in the case of infection, whereas cells in the presence of
c-Myc were passaged and plated on a 6 cm plate before being replated on
10 cm plate on day 9 in ESC medium. Cells were maintained in culture until
the appearance of GFP+ colonies.
Oct4 GFP+ colonies were mechanically isolated and individual cells were
dissociated and subsequently replated onto mitomycin C-treated MEFs.
Plasmid Construction
Plasmids containing the cDNA of Brg1 and Baf155 were purchased (Open Bio-
system). Brg1 and Baf155 were cloned into the retroviral vector pMX by using
NotI and EcoRI restriction sites. The clones pMXBrg1 and pMXBaf155 were
verified by sequencing.
Teratoma Formation and Histological Analysis
iPS cells were suspended at a concentration of 13 107 cells/ml in DMEM con-
taining 10% FBS. 100 ml of the cell suspension (1 3 106 cells) was injected
subcutaneously into the dorsal flanks of nude mice. Four weeks after the injec-
tion, tumors were surgically dissected from the mice. Samples were fixed in
PBS containing 4% formaldehyde and embedded in paraffin. Sections were
stained with hematoxylin and eosin.
Bisulfite Genomic Sequencing
Genomic DNA was isolated as per the manufacturer’s instructions (Roche).
Bisulfite sequencing method was based on our previously published protocol
(Han et al., 2008). PCR primers are listed in the Extended Experimental Proce-
dures.
Genotype Determination
Genotyping was performed on genomic DNA isolated from iPS cells as per the
manufacturer’s instructions (Roche). The genotype was determined using
TaqMan-based real-time PCR. Primers used for the detection of transgene
expression were also used for genotype determination.
Western Blot Analyses
Western blot was performed as previously described (Kim et al., 2008). Primary
antibodies used were anti-Oct3/4 mouse monoclonal antibody (sc-5279,
Santa Cruz), anti-Sox2 rabbit polyclonal antibody (ab 59776, Abcam), anti-
Klf4 goat polyclonal antibody (AF 3158, R&D), and anti-Brg1 mouse mono-
clonal antibody (sc-17796, Santa Cruz).
PCR andReal-TimePCR forMarker Gene and Transgene Expression
Total RNA was extracted from cells using the RNeasy Micro Kit (QIAGEN
GmbH) according to the manufacturer’s instructions. cDNA synthesis was per-
formed with the High Capacity cDNA Archive Kit (Applied Biosystems GmbH)
following the manufacturer’s instructions with a down-scaled reaction volume
of 20 ml. Transcript levels were determined using the ABI PRISM 7900
Sequence Detection System (Applied Biosystems) and the ready-to-use 50-
nuclease Assays-on-Demand. For real-time amplification, the template was
equivalent to 5 ng of total RNA. Quantification was normalized to the endoge-
nous Hprt1 gene within the log-linear phase of the amplification curve obtained
for each probe/primer set using the DDCt method (ABI PRISM 7700 Sequence
Detection System, user bulletin number 2);Hprt1was used as an internal stan-
dard. Oligonucleotides were designed by the TaqMan Assays-on-Demand.
Assay numbers are listed in Table S2. Primer sequences for viral-specific
Oct4, Sox2, Klf4, and c-Myc are as previously described (Kim et al., 2008);
35 cycles of semiquantitative PCR was carried out for the analysis for Oct4
and b-actin. PCR primers are listed in the Extended Experimental Procedures.
Whole Genome Expression Analysis
RNA samples to be analyzed on microarrays were prepared using QIAGEN
RNeasy columns with on-column DNA digestion. 400 ng of total RNA per
sample was used as input into a linear amplification protocol (Ambion), whichinvolved synthesis of T7-linked double-stranded cDNA and 12 hr of in vitro
transcription incorporating biotin-labeled nucleotides. Purified and labeled
cRNA was then hybridized for 18 hr onto MouseWG-6 v2 expression Bead-
Chips (Illumina) following the manufacturer’s instructions. After washing, as
recommended, chips were stained with streptavidin-Cy3 (GE Healthcare)
and scanned using the iScan reader (Illumina) and accompanying software.
Samples were exclusively hybridized as biological replicates.
Microarray Data Processing
For microarray data processing, the following was done: bead intensities were
mapped to gene information using BeadStudio 3.2 (Illumina); background
correction was performed using the Affymetrix Robust Multi-array Analysis
background correction model; variance stabilization was performed using
log2 scaling; and gene expression normalization was calculated with the quan-
tile method implemented in the lumi package of R-Bioconductor. Data post-
processing and graphics were performed with in-house developed functions
in MATLAB. Hierarchical clusters of genes and samples were performed
with a one minus correlation metric and the average (unweighted pair group)
linkage method.
In Vitro Differentiation of iPS Cells
Cells were harvested by trypsinization and transferred to bacterial culture
dishes in ESC medium without leukemia inhibitory factor. After 3 days in
culture, aggregated cells were plated onto gelatin-coated tissue culture dishes
and incubated for 5 days in the presence of 5 mM retinoic acid. Cells were
stained with anti-Tuj1 monoclonal antibody (Covance), anti-Sox17 antibody
(R&D Systems), or anti-Brachyury (Santa Cruz Biotechnology, Inc.) antibody
and counterstained with DAPI (Vector).
Chimera Formation
Chimera formation and germline transmission were carried out as described
previously (Kim et al., 2008). Briefly, iPS cells were aggregated and cultured
with denuded post-compacted eight-cell stage mouse embryos. After 24 hr
in culture, most aggregates had formed blastocysts. Aggregated blastocysts
were then transferred into the uterine horns of pseudopregnant mice.
Chromatin Immunoprecipitation Assay
ChIP was performed using the low cell number ChIP kit (Diagenode) according
to the manufacturer’s recommendations with minor modifications as follows.
Cells were collected by trypsinization, washed twice in PBS, crosslinked for
45 min at RT in disuccinimidyl glutarate (DSG; Pierce cat. no. 20593), and
then washed thrice in PBS and crosslinked in 1% formaldehyde for 8 min at
RT. Antibodies used in this experiment were anti-Oct3/4 goat polyclonal anti-
body (N-19; Santa Cruz) and goat polyclonal antibody (Santa Cruz). Primers
used for the ChIP analysis have been described in the Extended Experimental
Procedures.
ACCESSION NUMBERS
The microarray data discussed have been deposited in NCBI’s Gene
Expression Omnibus (Edgar et al., 2002) with accession number GSE18330
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18330).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, two
figures, five tables, and one movie and can be found with this article online
at doi:10.1016/j.cell.2010.04.037.
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